These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30738891)

  • 21. The Role of ADAM10 in Alzheimer's Disease.
    Yuan XZ; Sun S; Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2017; 58(2):303-322. PubMed ID: 28409746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells.
    Nord LC; Sundqvist J; Andersson E; Fried G
    Neurodegener Dis; 2010; 7(6):349-64. PubMed ID: 20523023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase inhibitor apicidin increases expression of the α-secretase ADAM10 through transcription factor USF1-mediated mechanisms.
    Hu XT; Zhu BL; Zhao LG; Wang JW; Liu L; Lai YJ; He L; Deng XJ; Chen GJ
    FASEB J; 2017 Apr; 31(4):1482-1493. PubMed ID: 28003340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer's Disease.
    Sathya M; Moorthi P; Premkumar P; Kandasamy M; Jayachandran KS; Anusuyadevi M
    J Alzheimers Dis; 2017; 60(s1):S3-S23. PubMed ID: 28059793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the beta secretase-1 inhibitor on the amyloid C-terminal fragment of amyloid precursor protein processing in a hyperphosphorylated tau rat model.
    Chen HY; Wang L; Liu JF; Wang WZ; Yu CJ
    Genet Mol Res; 2014 Aug; 13(3):6213-27. PubMed ID: 25158248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of amyloid-associated miRNAs in both the forebrain cortex and hippocampus of middle-aged rat.
    Che H; Sun LH; Guo F; Niu HF; Su XL; Bao YN; Fu ZD; Liu HL; Hou X; Yang BF; Ai J
    Cell Physiol Biochem; 2014; 33(1):11-22. PubMed ID: 24401368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
    Almeida CG; Tampellini D; Takahashi RH; Greengard P; Lin MT; Snyder EM; Gouras GK
    Neurobiol Dis; 2005 Nov; 20(2):187-98. PubMed ID: 16242627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin administration reverses the alteration of amyloid precursor protein-cleaving secretases expression in aged mouse hippocampus.
    Mukda S; Panmanee J; Boontem P; Govitrapong P
    Neurosci Lett; 2016 May; 621():39-46. PubMed ID: 27068758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoding the non-coding RNAs in Alzheimer's disease.
    Schonrock N; Götz J
    Cell Mol Life Sci; 2012 Nov; 69(21):3543-59. PubMed ID: 22955374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
    Tomita T
    Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau, APP, NCT and BACE1 in lymphocytes through cognitively normal ageing and neuropathology.
    Herrera-Rivero M; Soto-Cid A; Hernández ME; Aranda-Abreu GE
    An Acad Bras Cienc; 2013; 85(4):1489-96. PubMed ID: 24346801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disordered proteins in dementia.
    Ingelsson M; Hyman BT
    Ann Med; 2002; 34(4):259-71. PubMed ID: 12371710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-186 is decreased in aged brain and suppresses BACE1 expression.
    Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
    J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM10 in synaptic physiology and pathology.
    Musardo S; Marcello E; Gardoni F; Di Luca M
    Neurodegener Dis; 2014; 13(2-3):72-4. PubMed ID: 24008925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of Alzheimer's disease and frontotemporal dementia.
    Götz J; Ittner LM
    Nat Rev Neurosci; 2008 Jul; 9(7):532-44. PubMed ID: 18568014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain.
    Marcinkiewicz M; Seidah NG
    J Neurochem; 2000 Nov; 75(5):2133-43. PubMed ID: 11032903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.